Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine

Annals of the New York Academy of Sciences

Volumn 877, Issue , 1999, Pages 461-485

  Di Chiara, G ^a   Tanda, G ^a   Bassareo, V ^a   Pontieri, F ^a   Acquas, E ^a   Fenu, S ^a   Cadoni, C ^a   Carboni, E ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

AMYGDALOID NUCLEUS; CONDITIONING; CONFERENCE PAPER; DOPAMINERGIC TRANSMISSION; DRUG BIOAVAILABILITY; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; HABITUATION; HUMAN; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; RAT; STATE DEPENDENT LEARNING;

EID: 0032814694     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09283.x     Document Type: Conference Paper

References (96)

1. 1. Heimer, L. & R.D. Wilson. 1975, The subcortical projections of allocortex: similarities in the neuronal associations of the hippocampus, the piriform cortex and the neocortex. In Golgi Centennial Symposium Proceedings. M. Santini, Ed.: 173-193. Raven Press. New York.
2. 2. Heimer, L., J. De Olmos, G.F. Alheid & L. Zaborszky. 1991. "Perestroika" in the basal forebrain: opening the border between neurology and psychiatry. Prog. Brain Res. 87: 109-165.
3. 3. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM IV). Washington, D.C.
4. 4. Wikler, A. 1973. Dynamics of drug dependence: implications of a conditioning theory for research and treatment. Arch. Gen. Psychiatry 28: 611-616.
5. 5. O'Brien, C.P., A.R. Childress, A.T. McLellan & R. Ehrman. 1992. Classical conditioning in drug-dependent humans. Ann. N.Y. Acad. Sci. 654: 400-415.
6. 6. Stewart, J., H. De Wit & R. Eikelboom. 1984. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev. 91: 251-268.
7. 7. Goldberg, S.R. 1976. Stimuli associated with drug injections as events that control behavior. Pharmacol. Rev. 27: 325-340.
8. 8. Robinson, T.E. & K.C. Berridge. 1993. The neural basis of drug craving: an incentive-sensilization theory of addiction. Brain Res. Rev. 18: 247-291.
9. 9. Di Chiara, G. 1998. A motivational learning hypothesis of the role of dopamine in compulsive drug use. J. Psychopharmacol. 12: 54-67.
10. 10. Johanson, C.E. 1978. Drugs as reinforcers. In Contemporary Research in Behavioral Pharmacology. Blackman D.E. & D.J. Sanger, Eds.: 325-390. Plenum Press. New York.
11. 11. Ungerstedt, U. 1984. Measurements of neurotransmitter release by intracranial dialysis. In Measurement of Neurotransmitter Release in Vivo. C.A. Marsen, Ed.: 81-105. John Wiley. Chichester.
12. 12. Di Chiara, G. 1990. In vivo brain dialysis of neurotransmitters. Trends Pharmacol. Sci. II: 116-121.
13. 13. Di Chiara, G. & A. Imperato. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278.
14. 14. Carboni, E., A. Imperato, L. Perezzanni & G. Di Chiara. 1989. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-661.
15. 15. Di Chiara, G. & A. Imperato. 1988. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244: 1067-1080.
16. 16. Imperato, A., A. Mulas & G. Di Chiara. 1986. Nicotine preferentially stimulates dopamine released in the limbic system of freely moving rats. Eur. J. Pharmacol. 132: 337-338.
17. 17. Imperato, A. & G. Di Chiara. 1986. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther. 239: 219-228.
18. 18. Kuczenski, R. & D.S. Segal. 1992. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262: 1085-1094.
19. 19. Brazell, M.P., S.N. Mitchell, M.H. Joseph & J.A. Gray. 1990. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology 29: 1177-1185.
20. 20. Robinson, T.E. & D.M. Camp. 1990. Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology 3: 163-173.
21. 21. Di Chiara, G. 1991. On the preferential release of mesolimbic dopamine by ampheamine. Neuropsychopharmacology 5: 243-244.
22. 22. Di Chiara, G., G. Tanda, R. Frau & E. Carboni. 1993. On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes. Psychopharmacology 112: 398-402.
23. 23. Alheid, G.F. & L. Heimer. 1988. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid and corticopetal components of substantia innominata. Neuroscience 27: 1-39.
24. 24. Pontieri, F.E., G. Tanda & G. Di Chiara. 1995. Intravenous cocaine, morphine and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA. 92: 12304-12308.
25. 25. Pontieri, F.E., G. Tanda, F. Orzi & G. Di Chiara. 1996. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255-257.
26. 1 opioid receptor mechanism. Science 276: 2048-2050.
27. 27. Cadoni, C. & G. Di Chiara. 1999. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 90: 447-455.
28. 28. Heidbreder, C. & J. Feldon. 1998. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29: 310-322.
29. 29. Barrot, M., M. Marinelli, D.N. Abrous, F. Rougé-Pont, M. Le Moal & P.V. Piazza. 1998. Functional heterogeneity in dopamine release and in the expression of Fos-like proteins within the rat striatal complex. Eur. J. Neurosci. In press.
30. 30. Orzi, F., F. Passarelli, M. La Riccia, R. Di Grezia & F.E. Pontieri. 1996. Intravenous morphine increases glucose utilization in the shell of the rat nucleus accumbens. Eur. J. Pharmacol. 302: 49-51.
31. 31. Pontieri, F.E., V. Colangelo, M. La Riccia, C. Pozzilli, F. Passarelli & F. Orzi. 1994, Psychostimulant drugs increase glucose utilization in the shell of the rat nucleus accumbens. NeuroReport 5: 2561-2564.
32. 32. Bjorklund, A. & O. Lindvall. 1984. Dopamine containing systems in the CNS. In Handbook of Chemical Neuroanatomy. A. Biörklund & T. Hökfelt, Eds.; 2: 55-122. Classical transmitters in the CNS, part I. Elsevier. Amsterdam.
33. 33. Arnt, J. & T. Skarsfeldt. 1998. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence, Neuropsychopharmacology 18: 63-101.
34. 34. Ongini, E. & B.B. Fredholm. 1996. Pharmacology of adenosine A2 receptors. Trends Pharmacol. Sci. 17: 364-372.
35. 35. Bassareo, V., G. Tanda, P. Petromilli, C. Giua & G. Di Chiara. 1996. Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex. Psychopharmacology 124: 293-299.
36. 36. Tanda, G., F.E. Pontieri, R. Frau & G. Di Chiara. 1997. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 9: 2077-2085.
37. 37. Palkovits, M. 1979. Dopamine levels of individual brain regions: biochemical aspects of DA distribution in the central nervous system. In The Neurobiology of Dopamine. A.S. Horn, J. Korf & B.H.C. Westerink, Eds.: 343-356. Academic Press. London.
38. 38. Raiteri, M., R. Del Carmine, A. Bertollini & G. Levi. 1977. Effects of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine, Eur. J. Pharmacol. 41: 133-143.
39. 39. Carboni, E., G. Tanda, R. Frau & G. Di Chiara. 1990. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55: 1067-1070.
40. 40. Tanda, G., E. Carboni, R. Frau & G. Di Chiara. 1994. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115: 285-288.
41. 41. Cadoni, C., A. Pinna, G. Russi, S. Consolo & G. Di Chiara. 1995. Role of vescicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience 65: 1027-1039.
42. 42. Matthews, R.T. & D.C. German, 1984. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11:617-628.
43. 43. Gessa, G.L., F. Muntoni, M. Collu, L. Vargiu & G.P. Mereu. 1985. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 348: 201-203.
44. 44. Mereu, G., K.-W.P. Yoon, V. Boi, G.L. Gessa, L. Naes & T.C. Westfall. 1987. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur. J. Pharmacol. 141: 395-399.
45. 45. Cass, W.A., G.A. Gerhardt, R.D. Mayfield, P. Curella & N.R. Zahniser. 1992. Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J. Neurochem. 59: 259-266.
46. 1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur. J. Neurosci. 10: 1179-1187.
47. 3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol. 164: 515-519.
48. 48. Konokski, J. 1967. Integrative Activity of the Brain. University of Chicago Press. Chicago.
49. 49. Bassareo, V. & G. Di Chiara. 1997. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J. Neurosci. 17: 851-861.
50. 50. Bassareo, V. & G. Di Chiara. 1999. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience. 89(3): 637-641.
51. 51. Beninger, R.J. 1983. The role of dopamine in locomotor activity and learning. Brain Res. 6: 173-196.
52. 52. Acquas, E., E. Carboni, P. Leone & G. Di Chiara. 1989. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine receptor blockade? Psychopharmacology 99: 151-155.
53. 1 receptors blockade stereospecifically impairs the acquisition of drug-conditioned place-preference and place-aversion. Behav. Pharmacol. 5: 555-569.
54. 54. Caulliez, R., M.-J. Meile & S. Nicolaidis. 1996. A lateral hypothalamic DI dopaminergic mechanism in conditioned taste aversion. Brain Res. 729: 234-245.
55. 55. Parada, M.A., M.P. Deparada & B.G. Hoebel. 1995. Rats self-inject a dopamine antagonist in the lateral hypothalamus where it acts to increase extracellular dopamine in the nucleus accumbens. Pharmacol. Biochem. Behav. 52: 179-187.
56. 56. Phillips, G. & S.L. Morutto. 1998. Post-session sulpiride infusions within the perifornical region of the lateral hypothalamus enhance consolidation of associative learning. Psychopharmacology. In press.
57. 57. Hitchcott, P.K. & G.D. Phillips. 1998. Double dissociation of the behavioural effects of R(+) 7-OH-DPAT infusions in the central and basolateral amygdala nuclei upon Pavlovian and instrumental conditioned appetitive behaviours. Psychopharmacology. 140(4): 458-469.
58. 58. Mogenson, G.J., D.L. Jones & C.Y. Yim. 1980. From motivation to action: functional interface between the limbic system and the motor system. Prog. Ncurobiol. 14: 69-97.
59. 59. Salamone, J.D. 1988. Dopaminergic involvement in activational aspects of motivation: effects of haloperidol on schedule-induced activity, feeding and foraging in rats. Psychobiology 16: 196-206.
60. 60. Robbins, T.W., M. Cador, J.R. Taylor & B.J. Everitt. 1989. Limbic striatal interactions in reward-related processes. Neurosci. Behav. Rev. 13: 155-162.
61. 61. Salamone, J.D. 1992. Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes. Psychopharmacology 107: 160-174.
62. 62. Wise, R.A. 1982. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav. Brain Sci. 5: 39-87.
63. 63. Rescorla, R.A. & R.L. Solomon. 1967. Two-process learning theory: relationship between Pavlovian conditioning and instrumental learning. Psychol. Rev. 74: 151-182.
64. 64. Kelly, A.E., S.L. Smith-Roe & A.R. Holahan. 1997. Response reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proc. Natl. Acad. Sci. USA 94: 12174-12179.
65. 65. Holland, P.C. & J.J. Straub. 1979. Differential effects of two ways of devaluing the unconditioned stimulus after Pavlovian appetitive conditioning. J. Exp. Psychol. Anim. Behav. 5: 65-78.
66. 66. Di Chiara, G., E. Acquas, G. Tanda & C. Cadoni. 1993. Drugs of abuse: biochemical surrogates of specific aspects of natural reward? Biochem. Soc. Symp. 59: 65-81.
67. 67. Di Chiara, G. 1995. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38: 95-137.
68. 68. Himmelsbach, C.K. 1943. Morphine, with reference to physical dependence. Fed. Proc. Fed. Am. Soc. Exp. Biol. 2: 201-203.
69. 69. Solomon, R.L. 1977. An opponent-process theory of motivation: IV, The affective dynamics of addiction. In Psychopathology: Experimental Models. J.D. Maser & M.E.P. Seligman, Eds.: 66-103. Freeman. San Francisco.
70. 70. Koob, G.F., L. Stinus, M. Le Moal, & F.E. Bloom. 1989. Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci. Biobehav. Rev. 13: 135-140.
71. 71. Acquas, E., E. Carboni & G. Di Chiara. 1991. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmacol. 193: 133-134.
72. 72. Acquas, E. & G. Di Chiara. 1992. Depression of mesolimbic dopamine transmission and sensitizalion to morphine during opiate abstinence. J. Neurochem. 58: 1620-1625.
73. 73. Rossetti, Z.L., Y. Hmaidan & G.L. Gessa. 1992. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221: 227-234.
74. 74. Diana, M., M. Pistis, S. Carboni, G.L. Gessa & Z.L. Rossetti. 1993. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: eletrophysiological and biochemical evidence. Proc. Natl. Acad. Sci. USA 90: 7966-7969.
75. 75. Pothos, E., P. Rada, G.P. Mark & B.G. Hoebel. 1991. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566: 348-350.
76. 76. Weiss, F., A. Markou, M.T. Lorang & G.F. Koon. 1992. Basal dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593: 314-318.
77. 77. Diana, M., M. Pistis, A. Muntoni & G. Gessa. 1995. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272: 781-785.
78. 78. Emmett-Oglesby, M.W., D.A. Mathis, R.T.Y. Moon & H. Lal. 1990. Animal models of drug withdrawal symptoms. Psychopharmacology 101: 292-309.
79. 79. Bassareo, V., G. Tanda & G. Di Chiara. 1995. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence. Psychopharmacology 122: 202-205.
80. 80. Kolta, M.G., P. Shreve, V. De Souza & N.J. Uretsky. 1985. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24: 823-829.
81. 81. Segal, D.S. & R. Kuczenski. 1992. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577: 351-355.
82. 82. Segal, D.S. & R. Kuczenski. 1992. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571: 330-337.
83. 83. Kalivas, P.W. & P. Duffy. 1993. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13: 266-275.
84. 84. Wolf, M.E., F.J. White, R. Nassar, R.J. Brooderson & M.R. Khansa. 1993. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255.
85. 85. Consolo, S., M. Morelli, M. Rimoldi, S. Giorgi & G. Di Chiara. 1999. Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats. Neuroscience. 89(4): 1183-1187.
86. 86. Van De Witte, S.V., H.J. Groenewegen & P. Voorn. 1998. Augmentation of DI-agonist induced upregulation of preprodynorphin mRNA by L-DOPA priming is blocked by MK-801 in the 6-OHDA lesioned striatum. Collected Abstracts of Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse. Charlottesville, VA. No. P59. New York Academy of Sciences. New York.
87. 87. Hurd, Y.L., E.E. Brown, J.M. Finlay, H.C. Fibiger & C.R. Gerfen. 1992. Cocaine self-administration differentially alters mRNA expression of striatal peplides. Mol. Brain Res. 13: 165-170.
88. 88. Steiner, H. & C.R. Gerfen. 1993. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13: 5066-5081.
89. 89. Spangler, R., E.M. Unterwald & M.J. Kreek. 1993. "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. BrainRes. 19: 323-327.
90. 90. Daunais, J.B. & J.F. McGinty. 1994. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18: 35-45.
91. 91. Wang, J.Q. & J.F. McGinty. 1995. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673: 262-274.
92. 92. Tjon, G.H.K., P. Voorn, L.J.M.J. Vanderschuren, T.J. De Vries, N.H.L.M. Michiels, A.J. Jonker, H. Klop, P. Nestby, A.H. Mulder & A.N.M. Schof-felmeer, 1997. Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration. Neuroscience 76: 167-176.
93. 93. Neisewander, J.L., L.E. O'Dell, M.A. Ly, T.L. Tran-Nguyen, M.A. Edward Castañeda & R.A. Fuchs. 1996. Dopamine overflow in the nucleus accumbens during extinction and reinstatement of cocaine. Neuropsychopharmacology 15: 506-514.
94. 94. Angrist, B. 1994. Psychosis-inducing effects of cocaine may show sensitization more than other effects. Neuropsychopharmacology 10: 197S.
95. 95. Gawin, F.H. & M.E. Khalsa. 1996. Sensitizaiion and "street" stimulant addiction. In Neurotoxicity and Neuropathology Associated with Stimulant Abuse. M.D. Majewska, Ed.: 224-250. NIDA Research Monograph Series, U.S. Government Printing Office, Washington, DC.
96. 96. Segal, D.S. & R. Kuczenski. 1997. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J. Neurosci. 17: 2551-2566.